Meeting
2018 ASCO Annual Meeting
Mosaic TP53 pathogenic variants on multi-gene hereditary cancer panel testing: Clinical characteristics and follow-up testing.
Authors
Sarah A. Jackson
GeneDx, Inc., Gaithersburg, MD
Sarah A. Jackson , Maegan Roberts , Jessica L. Mester , Megan L. Marshall , Kristen J. Vogel Postula , Amy R. Stettner , Kevin J. Arvai , Rachel T. Klein , Andrew F. Wagner , Kathleen S. Hruska
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Hereditary Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 36, 2018 (suppl; abstr 1580)
DOI
10.1200/JCO.2018.36.15_suppl.1580
Abstract #
1580
Poster Bd #
151
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Determining concordance of LFSPRO TP53 germline carrier risk predictions to standard genetic counseling practice.
First Author: Elissa B. Dodd-Eaton
Poster
2022 ASCO Annual Meeting
Questioning a Li-Fraumeni Syndrome diagnosis: Characterization of a commonly observed germline TP53 variant, p.Arg156His.
First Author: Bita Nehoray
Poster
2022 ASCO Annual Meeting
Fertility preferences, concerns, and preservation among young women with breast cancer who carry germline genetic pathogenic variants compared with non-carriers.
First Author: Rebecca M. Lewinsohn
Poster
2020 ASCO Virtual Scientific Program
Genotype and phenotype correlation of common cancer predisposition syndromes in sarcoma cases.
First Author: Milita Zaheed